John T Baber, MD
Vascular Surgery · Oxnard
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 16 years
- Tulane University School of Medicine, 2010
Offices
1 location · Coastal Vascular Center PC · 4 clinicians in this group
Hospitals listed: Community Memorial Hospital - Ventura · St Johns Regional Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Baber’s office at (805) 983-6233 to ask if they take your plan before you enroll.
California Medical Board record
Licence A119504 · Current
Licensed to practise in California · since 2011 · expires 2027-03-31 · Tulane University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Community Memorial Hospital - VenturaVentura, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Memorial Health System, which runs 2 hospitalsPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.478, Oct 2024 – Sep 2025
- St Johns Regional Medical CenterOxnard, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 68% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.06 (90.32 to 169.81) · 120 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.404, Oct 2024 – Sep 2025
See every measure and the patient survey for Community Memorial Hospital - Ventura
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 11 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.478 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.95) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.82 (0.49 to 1.15) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 147.27 (93.9 to 200.65) · 66 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.3 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 86 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 120 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 273 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.8 · 363 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 3,592 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.36) · 5,727 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.1 to 0.49) · 5,976 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.6 (1.57 to 5.64) · 1,733 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.39 (0 to 2.97) · 688 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.97 (1.53 to 4.4) · 1,669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.87 (1.2 to 14.54) · 661 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.35 to 8.61) · 686 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.94 (0.47 to 3.41) · 327 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.19 (0 to 0.93) · 3,678 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3 · 218 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.548 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.157 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.228 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.373 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14 · 249 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.8 · 649 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -0.8 · 157 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -40.6 · 357 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -5 · 407 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 619 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.4 to 8) · 109 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9 (6.1 to 13) · 109 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 248 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10 · 90 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 164 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.2 (8.7 to 14.7) · 1,178 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 986 cases | No different | Jan 2024 – Dec 2024 |
What patients said (949 patients answered, 21% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 78% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 61% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for St Johns Regional Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 130.06 (90.32 to 169.81) · 120 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.404 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.8 (0 to 1.75) · 1,494 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.56 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 40 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.8 · 159 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 8.7 · 279 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.1 · 580 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.6 · 654 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 3,404 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.37) · 8,124 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.39) · 8,331 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.92 (1.89 to 5.95) · 1,414 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.17 (0.6 to 3.75) · 412 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.94 (0.46 to 3.43) · 1,361 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.75 (0.73 to 12.78) · 439 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.94 (3.39 to 10.49) · 383 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.94 (0.47 to 3.41) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.11 (0 to 0.67) · 7,172 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 88 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.236 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.331 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.571 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.737 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 336 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.8 · 715 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -8.1 · 284 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.6 · 648 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -9.1 · 674 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.9 · 670 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (5.2 to 8.9) · 428 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (8.6 to 13.5) · 428 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.9 · 98 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 49 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.1 · 196 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.5 to 18.8) · 247 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 486 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,151 patients answered, 18% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$270,991
Medicare paid this office $270,991 for 248 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 38 | $104,527 | $1,515 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 13 | $25,336 | $1,056 |
| Short return visit (20+ min) | 118 | $15,197 | $72 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 53 | $10,071 | $160 |
| Injection of chemical agent into multiple incompetent veins of leg | 22 | $9,993 | $178 |
See all 17 services
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 38 | $104,527 | $1,515 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 13 | $25,336 | $1,056 |
| Short return visit (20+ min) | 118 | $15,197 | $72 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 53 | $10,071 | $160 |
| Injection of chemical agent into multiple incompetent veins of leg | 22 | $9,993 | $178 |
| New patient visit (30+ min) | 77 | $6,630 | $86 |
| Return visit (30+ min) | 47 | $6,130 | $100 |
| Removal and/or dissolving of blood clot in hemodialysis circuit and balloon dilation of dialysis segment with imaging review by radiologist, with balloon tube | 12 | $4,612 | $329 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 28 | $3,741 | $107 |
| Ultrasound of leg arteries or artery grafts | 16 | $3,500 | $206 |
| New patient visit (45+ min) | 24 | $3,243 | $135 |
| Strapping, unna boot | 11 | $2,494 | $58 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,480 | $106 |
| Ultrasonic guidance for blood vessel access | 16 | $772 | $34 |
| Review by radiologist of abdominal aorta image | 11 | $579 | $53 |
| Ultrasonic guidance for blood vessel access | 25 | $391 | $11 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 16 | $174 | $10 |
Procedures Medicare counted
| Coronary artery bypass graft (CABG) | 1-10 | None |
| Leg revascularization (restoring blood flow) | 13 | More than 62% of doctors who do this |
| Spinal fusion | 1-10 | None |
| Varicose vein removal | 128 | More than 87% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Injection of chemical agent into multiple incompetent veins of leg | – | – | – | 40 | 44 | 56 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | – | 15 | – | – | 40 | 69 |
| Insertion of tunneled central venous tube for infusion (5 years or older) | – | 14 | 19 | 20 | 20 | – |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | – | – | 32 | 22 | – | – |
| Strapping, unna boot | – | – | – | – | – | 43 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | – | – | – | 12 | – | 24 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
248 Original Medicare patients in 2024. Average age 74 · Under 65 13% · 85 and older 19% · Women 60% · Also on Medicaid 48% · Health risk score 3.30. Above the middle of the specialty; the typical vascular surgery clinician is at 2.33.
Conditions among them: High blood pressure 75% · Diabetes 49% · Chronic kidney disease 44% · Coronary heart disease 37% · Heart failure 33% · Atrial fibrillation 27% · Depression 27% · Cancer 16% · Stroke 16% · COPD 14% · Dementia 10%.
The office billed $1,062,691, Medicare allowed $346,444 and paid $270,991; for 1,003 services of 90 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 248 | 1,003 | 74 | 3.30 | $1,062,691 | $270,991 |
| 2023 | 233 | 886 | 74 | 3.64 | $793,733 | $201,259 |
| 2022 | 223 | 909 | 74 | 3.32 | $611,737 | $166,210 |
| 2021 | 191 | 692 | 74 | 3.46 | $466,929 | $122,579 |
| 2020 | 603 | 1,500 | 73 | 3.90 | $1,371,248 | $206,574 |
| 2019 | 301 | 548 | 75 | 3.66 | $352,057 | $46,210 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 18 | $62,720 | $1,568 |
| Short return visit (20+ min) | 117 | $14,979 | $72 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 42 | $8,088 | $168 |
| Injection of chemical agent into multiple incompetent veins of leg | 12 | $7,643 | $174 |
| New patient visit (30+ min) | 56 | $4,782 | $85 |
| Ultrasound of leg arteries or artery grafts | 14 | $4,123 | $206 |
| Insertion of tunneled central venous tube for infusion (5 years or older) | 19 | $4,010 | $201 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 32 | $3,339 | $98 |
| Removal of tunneled central venous tube | 13 | $1,832 | $141 |
| New patient visit (45+ min) | 13 | $1,555 | $120 |
| Ultrasonic guidance for blood vessel access | 19 | $1,164 | $35 |
| Ultrasonic guidance for blood vessel access | 42 | $702 | $11 |
| Review by radiologist of abdominal aorta image | 11 | $591 | $54 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 23 | $252 | $10 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 17 | $247 | $14 |
2022: 18 services
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 12 | $22,755 | $1,034 |
| Short return visit (20+ min) | 104 | $15,731 | $75 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 46 | $9,371 | $164 |
| Injection of chemical agent into multiple incompetent veins of leg | 13 | $8,054 | $201 |
| New patient visit (30+ min) | 70 | $5,915 | $84 |
| Ultrasound of leg arteries or artery grafts | 16 | $4,301 | $226 |
| Insertion of tunneled central venous tube for infusion (5 years or older) | 18 | $3,924 | $196 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,594 | $113 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 11 | $2,366 | $197 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 15 | $1,601 | $100 |
| New patient visit (45+ min) | 11 | $1,431 | $130 |
| Ultrasonic guidance for blood vessel access | 11 | $1,252 | $35 |
| Return visit (30+ min) | 11 | $1,153 | $105 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 13 | $905 | $70 |
| Ultrasonic guidance for blood vessel access | 38 | $719 | $11 |
| Review by radiologist of abdominal aorta image | 12 | $618 | $51 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 22 | $291 | $10 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 15 | $261 | $15 |
2021: 13 services
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 21 | $40,392 | $1,262 |
| Short return visit (20+ min) | 72 | $9,055 | $72 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 28 | $6,052 | $168 |
| Insertion of tunneled central venous tube for infusion (5 years or older) | 19 | $4,080 | $215 |
| New patient visit (30+ min) | 44 | $3,905 | $89 |
| Return visit (30+ min) | 15 | $2,390 | $104 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 16 | $1,894 | $111 |
| Removal of tunneled central venous tube | 11 | $1,339 | $122 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,261 | $115 |
| Review by radiologist of abdominal aorta image | 14 | $912 | $57 |
| Ultrasonic guidance for blood vessel access | 38 | $524 | $12 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 30 | $369 | $11 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 20 | $313 | $16 |
2020: 20 services
| Ultrasound of leg arteries or artery grafts | 140 | $11,894 | $78 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 145 | $9,069 | $63 |
| Short return visit (20+ min) | 72 | $7,676 | $65 |
| New patient visit (30+ min) | 78 | $6,268 | $80 |
| Ultrasound of hemodialysis access | 129 | $6,210 | $38 |
| Ultrasound study of arm and leg arteries | 165 | $5,077 | $27 |
| Ultrasound of both sides of head and neck blood flow | 57 | $3,758 | $61 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 51 | $2,987 | $52 |
| Insertion of tunneled central venous tube for infusion (5 years or older) | 14 | $2,934 | $210 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 12 | $2,262 | $151 |
| Short return visit | 47 | $2,228 | $39 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,901 | $158 |
| Ultrasound of one leg arteries or artery grafts | 49 | $1,865 | $37 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 12 | $871 | $73 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 12 | $565 | $47 |
| Ultrasound of aorta, vena cava, groin vessels or bypass grafts | 12 | $553 | $46 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 43 | $524 | $10 |
| Insertion of tube into vena cava | 11 | $511 | $46 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 21 | $421 | $19 |
| Ultrasonic guidance for blood vessel access | 28 | $393 | $12 |
2019: 10 services
| Ultrasound of leg arteries or artery grafts | 64 | $3,559 | $55 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 53 | $2,718 | $51 |
| New patient visit (30+ min) | 18 | $1,679 | $93 |
| Ultrasound of hemodialysis access | 72 | $1,678 | $23 |
| Ultrasound of both sides of head and neck blood flow | 32 | $1,648 | $51 |
| Ultrasound study of arm and leg arteries | 77 | $1,307 | $17 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 39 | $1,074 | $28 |
| Ultrasound of one leg arteries or artery grafts | 28 | $652 | $23 |
| Ultrasound of aorta, vena cava, groin vessels or bypass grafts | 11 | $406 | $37 |
| Ultrasonic guidance for blood vessel access | 12 | $145 | $12 |
Medicaid work
$8,853 in 2024
Medicaid paid $8,853 for 210 billed services this clinician did in 2024, up to 29 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 152 | $4,230 |
| Injection of sclerosant; multiple incompetent veins (other than telangiectasia), same leg | 29 | $2,708 |
| New patient visit (30+ min) | 29 | $1,915 |
| 2024 | 210 | 3 | 29 | $8,853 |
| 2023 | 193 | 1 | 24 | $5,791 |
| 2022 | 206 | 2 | 21 | $6,417 |
| 2021 | 53 | 1 | 17 | $1,528 |
| 2020 | 26 | 2 | 14 | $1,321 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 193 | $5,791 |
2022
| Short return visit (20+ min) | 193 | $5,594 |
| New patient visit (30+ min) | 13 | $824 |
2021
| Short return visit (20+ min) | 53 | $1,528 |
2020
| Duplex scan of hemodialysis access (including arterial inflow, body of access and venous outflow) | 14 | $703 |
| LOWER EXTREMITY STUDY | 12 | $619 |
Drugs they prescribed that Part D paid
$33,376
Pharmacies billed $33,376 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 13% of their Part D prescriptions (28 of 210) in 2024. Above the middle of the specialty; the typical vascular surgery clinician is at 11%. Surgeons prescribe little besides pain medicine after an operation, so their opioid share runs high.
174 generic and 36 brand-name prescriptions · $33,376 in drug cost · 19 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 20 | $20,641 | $1,032 |
| Cilostazol | 25 | $610 | $24 |
| Lidocaine-Prilocaine | 26 | $471 | $18 |
| Clopidogrel | 28 | $264 | $9 |
| Hydrocodone-Acetaminophen | 22 | $123 | $6 |
Year by year
| 2024 | 210 | 84 | 13% (28) | 17% | $33,376 |
| 2023 | 166 | 73 | 16% (27) | 14% | $16,642 |
| 2022 | 109 | 58 | 25% (27) | None | $7,946 |
| 2021 | 97 | 48 | 19% (18) | 15% | $14,313 |
| 2020 | 126 | 45 | 20% (25) | None | $2,912 |
| 2019 | 15 | 12 | None | None | $792 |
| 2018 | 12 | None | 0% (0) | 0% | $157 |
| 2017 | 29 | 22 | 55% (16) | 0% | $345 |
| 2016 | 48 | 41 | 77% (37) | None | $897 |
| 2015 | 55 | 42 | 75% (41) | None | $1,004 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Xarelto | 12 | $9,623 | $802 |
| Pentoxifylline | 13 | $654 | $50 |
| Cilostazol | 11 | $389 | $35 |
| Lidocaine-Prilocaine | 11 | $216 | $20 |
| Hydrocodone-Acetaminophen | 15 | $121 | $8 |
| Doxycycline Hyclate | 11 | $81 | $7 |
2022: 3 drugs
| Lidocaine-Prilocaine | 13 | $276 | $21 |
| Hydrocodone-Acetaminophen | 20 | $153 | $8 |
| Triamcinolone Acetonide | 11 | $71 | $6 |
2021: 3 drugs
| Clopidogrel | 12 | $233 | $19 |
| Atorvastatin | 14 | $195 | $14 |
| Hydrocodone-Acetaminophen | 14 | $110 | $8 |
2020: 3 drugs
| Atorvastatin | 35 | $544 | $16 |
| Hydrocodone-Acetaminophen | 19 | $153 | $8 |
| Clopidogrel | 19 | $127 | $7 |
2018: 1 drug
| Clopidogrel | 11 | $141 | $13 |
2016: 2 drugs
| Hydrocodone-Acetaminophen | 17 | $190 | $11 |
| Oxycodone | 18 | $169 | $9 |
2015: 2 drugs
| Hydrocodone-Acetaminophen | 20 | $214 | $11 |
| Oxycodone | 11 | $168 | $15 |
Money from drug and device companies
$432 in 2025
| 2025 | 8 | 13 | None | $432 |
| 2024 | 6 | 7 | None | $623 |
| 2023 | 5 | 12 | None | $241 |
| 2022 | 5 | 14 | None | $384 |
| 2021 | 8 | 21 | None | $1,506 |
| 2020 | 6 | 11 | None | $730 |
| 2019 | 4 | 17 | None | $1,355 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| W. L. Gore & Associates | Gore Viabahn Vbx Balloon Expandable Endo | $191 | 3 payments
|
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $87 | 3 payments
|
| Medtronic | In.Pact Admiral | $36 | 2 payments
|
| LeMaitre Vascular | Restoreflow | $34 | 1 payment
|
| Vertex Pharmaceuticals | Journavx | $27 | 1 payment
|
| InspireMD | Cguard Prime Carotid Stent System | $20 | 1 payment
|
See all 13 published payments
| Vertex Pharmaceuticals | Meals · 2025-11-21 | Journavx | $27 |
| BSN Medical | Meals · 2025-11-19 | Jobst Relax | $18 |
| W. L. Gore & Associates | Meals · 2025-11-05 | Gore Viabahn Vbx Balloon Expandable Endo | $16 |
| W. L. Gore & Associates | Meals · 2025-11-05 | Gore Viabahn Vbx Balloon Expandable Endo | $142 |
| Medtronic | Meals · 2025-10-29 | Hawkone | $16 |
| LeMaitre Vascular | Meals · 2025-10-17 | Restoreflow | $34 |
| W. L. Gore & Associates | Meals · 2025-08-22 | Gore Tag Thoracic Branch Endoprosthesis | $33 |
| Shockwave Medical | Meals · 2025-08-19 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $21 |
| Smith+Nephew | Meals · 2025-07-30 | Collagenase Santyl | $19 |
| InspireMD | Meals · 2025-07-23 | Cguard Prime Carotid Stent System | $20 |
| Shockwave Medical | Meals · 2025-05-29 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $43 |
| Shockwave Medical | Meals · 2025-03-27 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $23 |
| Medtronic | Meals · 2025-02-19 | In.Pact Admiral | $20 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $623
| W. L. Gore & Associates | Gore Viabahn Vbx Balloon Expandable Endo | $241 | 2 payments
|
| Reflow Medical | None | $200 | 1 payment
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $114 | 1 payment
|
| Urgo Medical North America | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap | $26 | 1 payment
|
| Merck Sharp & Dohme | Bridion | $24 | 1 payment
|
| Medtronic | In.Pact Av | $19 | 1 payment
|
2023: $241
| Imperative Care | Prodigy Catheter | $74 | 3 payments
|
| LeMaitre Vascular | Hydro Lemaitre Valvulotome | $63 | 4 payments
|
| Inari Medical | Flowtriever Catheter, S | $44 | 2 payments
|
| Medtronic | Hawkone | $39 | 2 payments
|
| Tactile Systems Technology | Flexitouch Plus | $20 | 1 payment
|
2022: $384
| Medtronic | Concertotm | $207 | 7 payments
|
| Tactile Systems Technology | Flexitouch Plus | $66 | 4 payments
|
| Silk Road Medical | Enroute Transcarotid Neuroprotection System | $48 | 1 payment
|
| Smith+Nephew | Stravix | $39 | 1 payment
|
| Inari Medical | Flowtriever Catheter, S | $24 | 1 payment
|
2021: $1,506
| NuVasive | Alif | $830 | 4 payments
|
| Silk Road Medical | Enroute .014 Guidewire | $239 | 6 payments
|
| Penumbra | Indigo System | $150 | 1 payment
|
| Medtronic | Venaseal | $121 | 6 payments
|
| Philips Electronics North America | (6554) Peripheral Vascular Undivided | $108 | 1 payment
|
| Tactile Systems Technology | Flexitouch Plus | $22 | 1 payment
|
| CVRx | Barostim Neo System | $18 | 1 payment
|
| LeMaitre Vascular | Artegraft | $17 | 1 payment
|
2020: $730
| NuVasive | Alif | $605 | 4 payments
|
| Medtronic Vascular | In.Pact Av | $54 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $27 | 1 payment
|
| Silk Road Medical | Enroute Transcarotid Neuroprotection System | $21 | 1 payment
|
| Tactile Systems Technology | Flexitouch | $12 | 1 payment
|
| Pfizer | Eliquis | $11 | 1 payment
|
2019: $1,355
| Silk Road Medical | Enroute Transcarotid Neuroprotection System | $761 | 7 payments
|
| Cook Medical | Cook Medical Aaa | $412 | 7 payments
|
| Abbott Laboratories | Perclose Proglide Suture Mediated Closure System | $151 | 1 payment
|
| Medtronic Vascular | Hawkone | $31 | 2 payments
|
Checkups this office reported
8 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 82.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 0%That's few of the people this applied to. | 406 |
| Breast cancer screeningEligible women who got a mammogram | 0%That's few of the people this applied to. | 235 |
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 100%That's most of the people this applied to. Worse on this measure. | 48 |
| Medications listed in the chartVisits where the current medication list was documented | 65%That's more than half. | 1,524 |
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 0%That's few of the people this applied to. Better on this measure. | 375 |
| Screening for High Blood Pressure and Follow-Up DocumentedAs Medicare defines this measure | 13% | 1,314 |
| Statin prescribed when it protects the heartPeople at cardiovascular risk who were prescribed a statin | 65%That's more than half. | 89 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 18%That's few of the people this applied to. | 681 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Implementation of medication management practice improvements
- Improved the patient portal
- Lets patients read their visit notes
- Uses standard treatment protocols
Professional record
- NPI
- 1750607453
- Licence
- CA A119504California A119504: Current · expires 2027-03-31
- Trained
- Tulane University School of Medicine, 2010 · 16 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2086S0129X (2086S0129X)
- Mailing address
- 2841 N Ventura Rd Ste 200, Oxnard, CA, 93036
- NPI first listed
- 2010-04-20
- NPI last updated
- 2022-11-22
- NPI record certified
- 2022-11-22
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 10833 Le Conte Ave, Los Angeles, CA, 90095 · 100 N Brent St Ste 201, Ventura, CA, 93003